Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne J Lenaerts

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|June 1, 2015
Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelMichael A Lyons, Anne J Lenaerts
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Tuberculosis (Edinburgh, Scotland)|August 19, 2014
Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approachGavin J Ryan, Howard M Shapiro, Anne J Lenaerts
Tuberculosis (Edinburgh, Scotland)|November 5, 2004
Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse ratesAnne J Lenaerts, Phillip L Chapman, Ian M Orme
Trends in Microbiology|January 10, 2008
Preclinical testing of new drugs for tuberculosis: current challengesAnne J Lenaerts, Mary Ann Degroote, Ian M Orme
The Journal of Infectious Diseases|May 27, 2015
Nonclinical models for antituberculosis drug development: a landscape analysisTawanda Gumbo, Anne J Lenaerts, Debra Hanna, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
A physiologically based pharmacokinetic model of rifampin in miceMichael A Lyons, Brad Reisfeld, Raymond S H Yang, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary deliveryMercedes Gonzalez-Juarrero, Lisa K Woolhiser, Elizabeth Brooks, et al.
International Journal of Antimicrobial Agents|June 15, 2005
Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugsAnne J Lenaerts, Christine M Johnson, Karen S Marrieta, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted miceLisa K Woolhiser, Donald R Hoff, Karen S Marietta, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Journal of Pharmacokinetics and Pharmacodynamics|June 1, 2015
Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection modelMichael A Lyons, Anne J Lenaerts
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Tuberculosis (Edinburgh, Scotland)|August 19, 2014
Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approachGavin J Ryan, Howard M Shapiro, Anne J Lenaerts
Tuberculosis (Edinburgh, Scotland)|November 5, 2004
Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse ratesAnne J Lenaerts, Phillip L Chapman, Ian M Orme
Trends in Microbiology|January 10, 2008
Preclinical testing of new drugs for tuberculosis: current challengesAnne J Lenaerts, Mary Ann Degroote, Ian M Orme
The Journal of Infectious Diseases|May 27, 2015
Nonclinical models for antituberculosis drug development: a landscape analysisTawanda Gumbo, Anne J Lenaerts, Debra Hanna, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
A physiologically based pharmacokinetic model of rifampin in miceMichael A Lyons, Brad Reisfeld, Raymond S H Yang, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2012
Mouse model for efficacy testing of antituberculosis agents via intrapulmonary deliveryMercedes Gonzalez-Juarrero, Lisa K Woolhiser, Elizabeth Brooks, et al.
International Journal of Antimicrobial Agents|June 15, 2005
Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugsAnne J Lenaerts, Christine M Johnson, Karen S Marrieta, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted miceLisa K Woolhiser, Donald R Hoff, Karen S Marietta, et al.
Pageof 8